
Motus GI Holdings MOTS
Quartalsbericht 2024-Q1
hinzugefügt 14.05.2024
Motus GI Holdings EV/EBITDA 2011-2026 | MOTS
EV/EBITDA Jährlich Motus GI Holdings
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.351 | -1.79 | -1.64 | -2.39 | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 0.351 | -2.39 | -1.37 |
EV/EBITDA anderer Aktien in der Diagnostik & Forschung
| Name | EV/EBITDA | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Anixa Biosciences
ANIX
|
-2.25 | $ 2.85 | -3.72 % | $ 92.5 K | ||
|
Centogene N.V.
CNTG
|
0.387 | - | -6.23 % | $ 30.6 M | ||
|
Agilent Technologies
A
|
27.4 | $ 118.6 | 0.4 % | $ 36.1 B | ||
|
Aspira Women's Health
AWH
|
-2.63 | - | -6.19 % | $ 10.5 M | ||
|
Celcuity
CELC
|
-2.38 | $ 107.62 | -0.63 % | $ 4.25 B | ||
|
Fulgent Genetics
FLGT
|
2.58 | $ 13.82 | -2.68 % | $ 418 M | ||
|
Akumin
AKU
|
28.1 | - | -17.87 % | $ 25.9 M | ||
|
Castle Biosciences
CSTL
|
-21.2 | $ 27.55 | -1.59 % | $ 765 M | ||
|
Oxford Immunotec Global PLC
OXFD
|
-73.4 | - | - | $ 562 M | ||
|
Heska Corporation
HSKA
|
141 | - | - | $ 1.31 B | ||
|
HTG Molecular Diagnostics
HTGM
|
-1.42 | - | -20.0 % | $ 1.06 M | ||
|
Charles River Laboratories International
CRL
|
22 | $ 175.77 | -1.61 % | $ 8.71 B | ||
|
ICON Public Limited Company
ICLR
|
38 | $ 108.44 | 0.16 % | $ 8.94 B | ||
|
IDEXX Laboratories
IDXX
|
45.3 | $ 635.29 | -0.22 % | $ 51.1 B | ||
|
Accelerate Diagnostics
AXDX
|
-5.56 | - | -61.36 % | $ 2.46 M | ||
|
Global Cord Blood Corporation
CO
|
-3.52 | - | - | $ 399 M | ||
|
Laboratory Corporation of America Holdings
LH
|
8.7 | $ 283.19 | -1.07 % | $ 23.6 B | ||
|
Fluidigm Corporation
FLDM
|
-13.6 | - | 1.08 % | $ 308 M | ||
|
Genetic Technologies Limited
GENE
|
-2.67 | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
-2.67 | - | 0.12 % | $ 80.1 M | ||
|
Lantheus Holdings
LNTH
|
-187 | $ 79.15 | 3.74 % | $ 5.34 B | ||
|
PRA Health Sciences, Inc.
PRAH
|
20.8 | - | - | $ 10.7 B | ||
|
Mettler-Toledo International
MTD
|
827 | $ 1 315.61 | -0.56 % | $ 27.1 B | ||
|
Biodesix
BDSX
|
-4.25 | $ 15.5 | -1.59 % | $ 2.01 B | ||
|
Myriad Genetics
MYGN
|
-17.2 | $ 5.26 | 4.89 % | $ 487 M | ||
|
NeoGenomics
NEO
|
-33.5 | $ 9.53 | 0.26 % | $ 1.22 B | ||
|
Biocept
BIOC
|
-26.9 | - | -13.05 % | $ 7.29 M | ||
|
National Research Corporation
NRC
|
21 | $ 13.37 | -3.47 % | $ 328 M | ||
|
Natera
NTRA
|
-19.5 | $ 206.39 | 3.11 % | $ 20.3 B | ||
|
Invitae Corporation
NVTA
|
-10.7 | - | - | $ 21.2 M | ||
|
BioNano Genomics
BNGO
|
-7.71 | $ 1.12 | -1.78 % | $ 1.42 M | ||
|
Quest Diagnostics Incorporated
DGX
|
5.51 | $ 208.28 | -0.95 % | $ 23.1 B | ||
|
Danaher Corporation
DHR
|
20.1 | $ 204.04 | -0.9 % | $ 145 B | ||
|
Organovo Holdings
ONVO
|
0.992 | - | -2.3 % | $ 19.4 M | ||
|
OPKO Health
OPK
|
25.9 | $ 1.22 | -2.02 % | $ 847 M | ||
|
Pacific Biosciences of California
PACB
|
-23.8 | $ 1.51 | -7.1 % | $ 453 M | ||
|
Exact Sciences Corporation
EXAS
|
-20.8 | $ 103.38 | 0.02 % | $ 19.5 B | ||
|
Bioventus
BVS
|
26.4 | $ 8.8 | 0.34 % | $ 551 M | ||
|
DarioHealth Corp.
DRIO
|
-1.05 | $ 10.3 | -4.19 % | $ 292 M | ||
|
DexCom
DXCM
|
39.5 | $ 73.0 | -1.06 % | $ 28.5 B | ||
|
PerkinElmer
PKI
|
18.8 | - | -0.91 % | $ 14.7 B | ||
|
Psychemedics Corporation
PMD
|
15.9 | - | -1.84 % | $ 15.3 M | ||
|
Precipio
PRPO
|
-1.8 | $ 24.78 | 0.38 % | $ 32.2 M | ||
|
QIAGEN N.V.
QGEN
|
13.2 | - | - | $ 10.6 B | ||
|
Quotient Limited
QTNT
|
-5.32 | - | -11.32 % | $ 1.1 M | ||
|
Burning Rock Biotech Limited
BNR
|
-1.51 | $ 24.01 | -4.59 % | $ 254 M | ||
|
Illumina
ILMN
|
70.5 | $ 129.9 | -2.25 % | $ 20.7 B | ||
|
Renalytix AI plc
RNLX
|
-32.1 | - | 5.66 % | $ 22.7 M | ||
|
VolitionRx Limited
VNRX
|
-3.45 | $ 0.2 | -0.74 % | $ 19.2 M |